Experimental eye implant aims to halt vision loss in dry AMD
NCT ID NCT06557460
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This Phase IIb trial tests a retinal implant (CPCB-RPE1) in 24 people with advanced dry age-related macular degeneration (geographic atrophy). Participants are randomly assigned to receive the implant or a sham procedure. The study measures changes in retinal sensitivity and visual acuity over time to see if the implant can slow or improve vision loss.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
CPCB-RPE1 implant (a retinal cell implant)
What this could lead to
If successful, this implant could slow vision loss or improve sight in people with advanced dry AMD, offering a new treatment option.
What could go wrong
This is an early Phase IIb trial with only 24 people. The implant requires surgery, which carries risks like infection or retinal detachment. It may not work better than a sham procedure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GEOGRAPHIC ATROPHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Retina Associates of Southern California
RECRUITINGHuntington Beach, California, 92647, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Retina Consultants of Texas
RECRUITINGThe Woodlands, Texas, 77384, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Retina-Vitreous Associates Medical Group
RECRUITINGBeverly Hills, California, 90211, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
USC - Keck
RECRUITINGLos Angeles, California, 90033, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University Retina
RECRUITINGLemont, Illinois, 60439, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••